Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4186468 | 0.87 | CETP (0.44) | CETPTACR1 | |
| SCHEMBL3574603 | 0.85 | CETP (0.37) | CETPTACR1 | |
| SCHEMBL3573798 | 0.85 | CETP (0.37) | CETPTACR1 | |
| SCHEMBL13918433 | 0.83 | TACR1 (0.38) | CETPTACR1 | |
| SCHEMBL3224312 | 0.82 | TACR1 (0.38) | CETPTACR1 | |
| SCHEMBL3579894 | 0.82 | CETP (0.37) | CETPTACR1 | |
| SCHEMBL3578647 | 0.82 | CETP (0.37) | CETP | |
| SCHEMBL4223079 | 0.82 | CETP (0.38) | CETP | |
| SCHEMBL3569455 | 0.81 | CETP (0.36) | CETP | |
| SCHEMBL3215672 | 0.81 | CETP (0.41) | CETP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100076021-A1 | Organic Compounds | IMASE HIDETOMO | 2010-03-25 | — | — | US | disclosed |
| US-20100076021-A1 | Organic Compounds | IMASE HIDETOMO | 2010-03-25 | — | — | US | disclosed |
| US-20100076021-A1 | Organic Compounds | IMASE HIDETOMO | 2010-03-25 | — | — | US | disclosed |
| EP-2084149-A1 | ORGANIC COMPOUNDS | Novartis AG (CH) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008058967-A1 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2008-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100076021-A1 | Organic Compounds | CETP, NPC1, LCAT | CETP 1/4885TACR1 1439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.